Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
MOTS-c
Batch #
N/A
Formula
C101H152N28O22S2
Mol Wt
2174.64 g/mol
CAS
1627580-64-6
Latest
ISO 17025
8× Testing
99.5%
Purity
VariantMOTS-c
COA ##13124
Labeled40mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.5%
✓
Net Peptide Content - 40mg
✓
Identity (HPLC) - MOTS-c
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
02
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
03
Targeting AMPK pathways by MOTS-c in diabetes
04
MOTS-c: a mitochondrial-derived peptide involved in metabolism regulation and the biology of aging
05
MOTS-c links mitochondria and the endocrine system to combat metabolic dysfunction in aging
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
